NCT05835934View on ClinicalTrials.gov

Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK21542 in Healthy Adult Male Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

September 10, 2021

Study Completion Date

December 20, 2021

Conditions
Peripheral Analgesic and Anti-itch
Interventions
DRUG

[14C]HSK21542

A single intravenous dose of 2 μg/0.212 μCi/kg \[14C\]HSK21542 in boluses within 2 minute after fasting for at least 10 hours.

Trial Locations (1)

Unknown

f the First Affiliated Hospital of soochow University, Suzhou

All Listed Sponsors
collaborator

The First Affiliated Hospital of Soochow University

OTHER

lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY